Geographic disparity in 10-year mortality after coronary artery revascularization in the SYNTAXES trial

Shigetaka Kageyama1, Patrick W Serruys2, Scot Garg3

  • 1Department of Cardiology, National University of Ireland, Galway (NUIG), Galway, Ireland.

Insights

This study on complex coronary artery disease (CAD) found lower 10-year mortality in Eastern, Northern, and Southern Europe compared to Western Europe after revascularization. Geographic disparities in outcomes exist following percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).

Area of Science:

  • Cardiology
  • Global Health
  • Clinical Trials

Background:

  • Complex coronary artery disease (CAD) requires revascularization via percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).
  • Geographic variations in healthcare access and patient characteristics may influence long-term outcomes.
  • The SYNTAXES trial provides a unique dataset to explore these disparities.

Purpose of the Study:

  • To investigate geographic disparities in long-term mortality following revascularization in patients with complex CAD.
  • To compare 10-year survival rates across different recruitment regions in the SYNTAXES trial.
  • To identify potential factors contributing to observed regional differences in mortality.

Main Methods:

  • Analysis of the SYNTAXES trial data, randomizing 1800 patients with three-vessel and/or left main CAD to PCI or CABG.
  • Stratification of patients based on recruitment region: North America, Eastern Europe, Northern Europe, Southern Europe, and Western Europe (reference).
  • Assessment of 10-year survival, with adjustments for pre- and peri-procedural factors.

Main Results:

  • Crude 10-year mortality was significantly lower in Eastern Europe (22.5%), Northern Europe (21.9%), and Southern Europe (22.0%) compared to Western Europe (30.7%).
  • Adjusted mortality remained significantly lower in Northern Europe (HR 0.85) and Southern Europe (HR 0.72) compared to Western Europe.
  • Patient demographics and baseline characteristics varied significantly across regions, including age, sex, diabetes, peripheral vascular disease, ejection fraction, and anatomic SYNTAX score.

Conclusions:

  • Significant geographic disparities in 10-year mortality following revascularization for complex CAD exist.
  • Lower mortality rates in Eastern, Northern, and Southern Europe suggest potential regional advantages or differing patient populations.
  • Understanding these geographic variations is crucial for interpreting global clinical trial data and optimizing patient care worldwide.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
29
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
48
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
67
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
28
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31